Calidi Biotherapeutics CLDI
NYSE CLDI
$1.06 -0.01 (-0.93%)
As of: Oct 1, 2026 · 12:58 PM EDT

Calidi Biotherapeutics (CLDI) Notes Payables (2022 - 2024)

Updated

Calidi Biotherapeutics (CLDI) reported Notes Payables of $1.02 million for Q1 2024, down 30.2% from $1.46 million a year earlier.

Analysis

Calidi Biotherapeutics (CLDI) Notes Payables (2022 - 2024) Analysis & Trends

At the end of FY2022, Calidi Biotherapeutics posted Notes Payables of $1.22 million.

  • The Q1 2024 figure ranks as the lowest quarterly Notes Payables since Q3 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Calidi Biotherapeutics 1.50 Mn -23.88 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 1.02 Mn
Jun 30, 2023 1.49 Mn
Mar 31, 2023 1.46 Mn
Dec 31, 2022 1.22 Mn
Sep 30, 2022 460,000.00
API Access

Calidi Biotherapeutics Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=CLDI&period=max&api_key=YOUR_API_KEY